The pancreas as a source of cardiovascular cell activating factors

Microcirculation

Volumn 7, Issue 3, 2000, Pages 183-192

  Kistler, Erik B ^a   Hugli, Tony E ^b   Schmid Schönbein, Geert W ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelium; Free radicals; Neutrophil; Protease; Pseudopod formation; Shock

Indexed keywords

PSEUDOPODA;

BIOLOGICAL FACTOR; CHEMOTACTIC FACTOR; COLORING AGENT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FREE RADICAL; GUANIDINE DERIVATIVE; NAFAMSTAT; NITROBLUE TETRAZOLIUM; SERINE PROTEINASE INHIBITOR; SUPEROXIDE;

ANIMAL; ARTICLE; BLOOD PRESSURE; CELL SURVIVAL; CHEMISTRY; CHEMOLUMINESCENCE; DRUG EFFECT; ISOLATION AND PURIFICATION; MALE; METABOLISM; MOLECULAR WEIGHT; NEUTROPHIL; PANCREAS; PATHOPHYSIOLOGY; PSEUDOPODIUM; RAT; RESPIRATORY BURST; SHOCK; SWINE; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; BIOLOGICAL FACTORS; BLOOD PRESSURE; CELL SURVIVAL; CHEMILUMINESCENT MEASUREMENTS; CHEMOTACTIC FACTORS; COLORING AGENTS; FREE RADICALS; GUANIDINES; MALE; MOLECULAR WEIGHT; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; NITROBLUE TETRAZOLIUM; PANCREAS; PSEUDOPODIA; RATS; RATS, WISTAR; RESPIRATORY BURST; SERINE PROTEINASE INHIBITORS; SHOCK; SUPEROXIDES; SWINE;

EID: 0034203653     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2000.tb00119.x     Document Type: Article

References (35)

1. Abello PA, Buchman TG, Bulkley GB. (1994). Shock and multiple organ failure. Adv Exp Med Biol 366: 253-268.
2. Barroso-Aranda J, Chavez-Chavez R, Mathison JC, Suematsu M, Schmid-Schönbein GW. (1994). Circulating neutrophil kinetics during tolerance in hemorrhagic shock using bacterial lipopolysaccharide. Am J Physiol H415-11421.
3. Barroso-Aranda J, Chavez-Chavez R, Schmid-Schönbein GW. (1992). Spontaneous neutrophil activation and the outcome of hemorrhagie shock in rabbits. Circ Shock 36:185-190.
4. Barroso-Aranda J, Schmid-Schönbein GW. (1989). Transformation of neutrophils as indicator of irreversibility in hemorrhagic shock. Am J Physiol 257:H846-H852.
5. Barroso-Aranda J, Zweifach BW, Mathison JC, Schmid-Schönbein GW. (1995). Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock. J Cardiovasc Pharmacol 25:S23-S29.
6. Barry MC, Wang JH, Kelly CJ, Sheehan SJ, Redmond HP, Bouchier-Hayes DJ. (1997). Plasma factors augment neutrophil and endothelial cell activation during aortic surgery. Eur J Vasc Endovasc Surg 13:381-387.
7. Buckley GB. (1989). Mediators of splanchnic organ injury: overview and perspective. In: Splanchnic Arterial Occlusion Shock. (A Marston, GB Buckley, RG Fiddian-Green, and UH Haglund, Eds.) The C.V. Mosby Company. St. Louis. 183-191.
8. Carden DL, Young JA, Granger DN. (1993). Pulmonary microvascular injury after intestinal ischemia-reperfusion: role of P-selectin. J Appl Physiol 75: 2529-2534.
9. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K. (1996). Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascuLar diseases. Stroke 27:1734-1738.
10. Emerit I, Fabiani JN, Levy A, Ponzio O, Conti M, Brasme B, Bienvenu P, Hatmi M. (1995). Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes. Free Radic Biol Med 19:405-415.
11. Ferguson WW, Glenn TM, Lefer AM. (1972). Mechanisms of production of circulatory shock factors in isolated perfused pancreas. Am J Physiol 222:450-457.
12. Frank E. (1968). Traumatic and toxic factors in shock. In: Microcirculation as Related to Shock. (D Shepro and GP Fulton, Eds.) Academic Press. New York. 181-196.
13. Glenn TM, Herlihy BL, Ferfuson WW, Lefer AM. (1972). Protective effect of pancreatic duct ligation in splanchnic ischemia shock. Am J Physiol 222:1278-1284.
14. Glenn TM, Lefer AM. (1971). Significance of splanchnic proteases in the production of a toxic factor in hemorrhagic shock. Circ Res 29:338-349.
15. Huang TS, Hurd RE, Chopra IJ, Stevens P, Solomon DH, Young LS. (1984). Inhibition of phagocytosis and chemiluminescence in human leukocytes by a lipid soluble factor in normal tissues. Infect Immun 46:544-551.
16. Kistler EB. (1998). Humoral Mechanisms of Cellular Activation in Ischemic Shock. Ph.D. Thesis, University of California, San Diego.
17. Kistler KB, Lefer AM, DeLano FA, Zweifach BW, Schmid-Schönbein GW. (1990). Splanchnic arterial occlusion shock and plasma activation in the rat. International Journal of Microcirculalion 16(suppl. 1): 202.
18. Kistler EB, Lefer AM, Hugli TE, Schmid-Schönbein GW. (2000). Plasma activation during splanchnic arterial occlusion shock. Shock (in press).
19. Klar E, Messmer K, Warshaw AL, Herfarth C. (1990). Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg 77:1205-1210.
20. Kusterer K, Poschmann T, Friedemann A, Enghofer M, Zendler S, Usadel KH. (1993). Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 265:G165-G171.
21. Lacy F, O'Connor DT, Schmid-Schönbein GW. (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16:291-303.
22. Lefer AM. (1977). Production of a myocardial depressant factor in circulatory shock. In: Current Topics in Critical Care Medicine. (WC Shoemaker and BM Taveres, Eds.) S. Karger. Basel, Switzerland. 80-93.
23. Leffler JN, Litvin Y, Barenholz Y, Lofer AM. (1973). Proteolysis in formation of a myocardial depressant factor during shock. Am J Physiol 224:824-831.
24. Marston A. (1989). Vascular occlusion. In: Splanchnic Arterial Occlusion Shock. (A Marston, GB Buckley, RG Fiddian-Green, and UH Haglund, Eds.) The C.V. Mosby Company. St. Louis. 51-71.
25. McCord JM. (1985). Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163.
26. Mitsuoka H, Kistler EB, Schmid-Schönbein GW. (2000). Generation of in vitro activating factors in the Ischemic intestine by pancreatic enzymes. Proc Natl Acad Sci USA 97:1772-1777.
27. Montgomery A, Borgstrom A, Haglund U. (1992). Pancreatic proteases and intestinal mucosal injury after ischemia and reperfusion in the pig. Gastroenterology 102:216-222.
28. Ohoi I, Sone K, Tobari H, Kawano E, Nakamura K. (1993). A simple chemiluminescence method for measuring oxygen-derived free radicals generated in oxygenated rat myocardium. Jpn J Pharmacol 61: 101-107.
29. Paterson IS, Smith FC, Tsang GM, Hamer JD, Shearman CP. (1993). Reperfusiori plasma contains a neutrophil activator. Ann Vasc Surg 7:68-75.
30. Schmeling DJ, Caty MG, Oldham KT, Guice KS, Hinshaw DB. (1989). Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery 106:195-201; discussion 201-202.
31. Seitz R, Adler G, Koop I, Koop H, Egbring R. (1989). A unique case of intravenous injection of fungal "pancreatic" enzymes causing shock and proteolysis of haemostatic proteins. Toxicology 55:239-246.
32. Shen K, Chavez-Chavez R, Loo A, Zweifach BW, Barroso-Aranda J, Schmid-Schönbein GW. (1990). Interpretation of leukocyte activation measurements from systemic blood vessels. Circulatory Shock 31: 343-344.
33. Sofianos A. (1999). A Partial Characterization of Pancreatic Activating Factors. Master's Thesis, University of California, San Diego.
34. Suematsu M, DeLano FA, Poole D, Engler RL, Miyasaka M, Zweifach BW, Schmid-Schönbein GW. (1994). Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation. Lab Invest 70:684-695.
35. Warshaw AL, O'Hara PJ. (1978). Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 188:197-201.